| It cannot be reversed that the world economy is integrating and getting globalization. Every nation's resources can fluently exchange and collocate. As a result, internationalized management is the only choice for the global firms. The cosmopolitan of the demand for the medicine and the centrality of the production make the medicine one of the extensive exports; and this brings only a fewer developed countries play an important role in the world medicine market. After 30 years'development, our chemical pharmaceutical industry made a enormous progress, formed a group of competitive corporation. If we want make further progress, we must export more API to European and American market. Upgrade our management ability and satisfy their cGMP requirements is the most urgent affairs.The thesis regards the Zhejiang HZ Pharmaceutical Company, a well-known pharmaceutical enterprise, as the studying object. It analyzes and evaluates the transnational strategy, course, activity models and internationalized management, expressing some issues, and pointing out some advised countermeasures. From the company we can find some useful tools, which can improve our pharmaceutical industry's international competive power and seize the historical opportunity of pharmaceutical industry international transfer.First, the thesis introduces the current situation of our pharmaceutical company's internationalized management, pointing out the advantage and conditionality which we are faced with. Then, through case studying, it reviews some modus operandi of HZ company's internationalized management, analyze their successful experience on international registration and technique progress. Finally, the thesis point that marketing registration, technique progress and invite key person with ability are three means which can improve your internationalized management level, which will be helpful for those pharmaceutical enterprises who want to enter the international market. |
PDF Full Text Request